Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Baier-Bitterlich

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Neuroscience Letters|December 18, 2001
Influence of cytokines tumor necrosis factor-alpha and interferon-gamma on signaling cascades associated with apoptosis in rat PC12 cellsC Enzinger, B Wirleitner, G Böck, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Kynurenine and pteridines in changes of membrane fluidityV Rudzite, E Jurika, D Fuchs, et al.
Biochemical Pharmacology|November 5, 1998
7,8-Dihydroneopterin-induced apoptosis in Jurkat T lymphocytes: a comparison with anti-Fas- and hydrogen peroxide-mediated cell deathB Wirleitner, G Baier-Bitterlich, G Böck, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Activated cellular immunity and decreased serum tryptophan in healthy pregnancyD Fuchs, H Schröcksnadel, G Baier-Bitterlich, et al.
Obstetrics and Gynecology|July 1, 1996
Decreased plasma tryptophan in pregnancyH Schröcksnadel, G Baier-Bitterlich, O Dapunt, et al.
Life Sciences|March 3, 1995
The role of p56lck in CD4-mediated suppression of CD3-induced early signaling events in T lymphocytesG Baier-Bitterlich, G Baier, E Gulbins, et al.
Oncogene|January 1, 1994
Transcellular activation of the HTLV promoter by human hematopoietic cellsG Baier-Bitterlich, J Rappaport, G Baier, et al.
Arzneimittel-Forschung|March 1, 1993
Effects of D-penicillamine on human cell linesG Baier-Bitterlich, W Schumacher, T F Schulz, et al.
Free Radical Biology & Medicine|January 1, 1997
Neopterin derivatives to activate NF-kappa BB Wirleitner, G Baier-Bitterlich, G Hoffmann, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS)V Rudzite, J Berzinsh, I Grivane, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Neuroscience Letters|December 18, 2001
Influence of cytokines tumor necrosis factor-alpha and interferon-gamma on signaling cascades associated with apoptosis in rat PC12 cellsC Enzinger, B Wirleitner, G Böck, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Kynurenine and pteridines in changes of membrane fluidityV Rudzite, E Jurika, D Fuchs, et al.
Biochemical Pharmacology|November 5, 1998
7,8-Dihydroneopterin-induced apoptosis in Jurkat T lymphocytes: a comparison with anti-Fas- and hydrogen peroxide-mediated cell deathB Wirleitner, G Baier-Bitterlich, G Böck, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Activated cellular immunity and decreased serum tryptophan in healthy pregnancyD Fuchs, H Schröcksnadel, G Baier-Bitterlich, et al.
Obstetrics and Gynecology|July 1, 1996
Decreased plasma tryptophan in pregnancyH Schröcksnadel, G Baier-Bitterlich, O Dapunt, et al.
Life Sciences|March 3, 1995
The role of p56lck in CD4-mediated suppression of CD3-induced early signaling events in T lymphocytesG Baier-Bitterlich, G Baier, E Gulbins, et al.
Oncogene|January 1, 1994
Transcellular activation of the HTLV promoter by human hematopoietic cellsG Baier-Bitterlich, J Rappaport, G Baier, et al.
Arzneimittel-Forschung|March 1, 1993
Effects of D-penicillamine on human cell linesG Baier-Bitterlich, W Schumacher, T F Schulz, et al.
Free Radical Biology & Medicine|January 1, 1997
Neopterin derivatives to activate NF-kappa BB Wirleitner, G Baier-Bitterlich, G Hoffmann, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS)V Rudzite, J Berzinsh, I Grivane, et al.
Pageof 5